M810-2791 Screening compound: N-{4-[6-ethyl-2-(propan-2-yl)imidazo[2,1-b][1,3,4]thiadiazole-5-sulfonamido]phenyl}acetamide

M810-2791 Screening compound: N-{4-[6-ethyl-2-(propan-2-yl)imidazo[2,1-b][1,3,4]thiadiazole-5-sulfonamido]phenyl}acetamide
M810-2791 Screening compound: N-{4-[6-ethyl-2-(propan-2-yl)imidazo[2,1-b][1,3,4]thiadiazole-5-sulfonamido]phenyl}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound M810-2791
N-{4-[6-ethyl-2-(propan-2-yl)imidazo[2,1-b][1,3,4]thiadiazole-5-sulfonamido]phenyl}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

M810-2791

Molecular Formula

C17H21N5O3S2 (C17 H21 N5 O3 S2)

Compound Name

N-{4-[6-ethyl-2-(propan-2-yl)imidazo[2,1-b][1,3,4]thiadiazole-5-sulfonamido]phenyl}acetamide

IUPAC name

N-{4-[6-ethyl-2-(propan-2-yl)imidazo[21-b][134]thiadiazole-5-sulfonamido]phenyl}acetamide

SMILES

CCc(nc1sc(C(C)C)nn11)c1S(Nc(cc1)ccc1NC(C)=O)(=O)=O

InChI

InChI=1S/C17H21N5O3S2/c1-5-14-16(22-17(19-14)26-15(20-22)10(2)3)27(24,25)21-13-8-6-12(7-9-13)18-11(4)23/h6-10,21H,5H2,1-4H3,(H,18,23)

InChI Key

ZAUBKDBKBSWIMU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27554809

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

407.52

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.902

Distribution Coefficient, logD

2.883

Water Solubility, LogSw

-3.39

Polar Surface Area

86.397

Acid Dissociation Constant (pKa)

8.76

Base Dissociation Constant (pKb)

2.18

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

35.30

M810-2791 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

BRD4 Targeted Library (4534 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Hemic and lymphatic
  • Cardiovascular
  • Metabolic
Targets:
  • Others

References: we are preparing a list of scientific research reports with M810-2791 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound M810-2791?
Check Price and Availability of M810-2791, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of M810-2791 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for M810-2791
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for M810-2791
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of M810-2791 available by request